Revelation Biosciences Inc [NASDAQ: REVB] stock went on an upward path that rose over 6.01% on Wednesday, amounting to a one-week price decrease of less than -9.52%.
Over the last 12 months, REVB stock dropped by -88.84%. The one-year Revelation Biosciences Inc stock forecast points to a potential upside of 88.38. The average equity rating for REVB stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $4.20 million, with 1.70 million shares outstanding and 1.70 million shares in the current float. Compared to the average trading volume of 187.86K shares, REVB stock reached a trading volume of 12905996 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Revelation Biosciences Inc [REVB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for REVB shares is $21.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on REVB stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 0.99, with the Price to Cash per share for the same quarter was set at 3.04.
REVB Stock Performance Analysis:
Revelation Biosciences Inc [REVB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.52. With this latest performance, REVB shares gained by 3.78% in over the last four-week period, additionally sinking by -75.35% over the last 6 months – not to mention a drop of -88.84% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for REVB stock in for the last two-week period is set at 42.62, with the RSI for the last a single of trading hit 0.28, and the three-weeks RSI is set at 0.27 for Revelation Biosciences Inc [REVB]. The present Moving Average for the last 50 days of trading for this stock 2.67, while it was recorded at 2.66 for the last single week of trading, and 10.24 for the last 200 days.
Revelation Biosciences Inc (REVB) Capital Structure & Debt Analysis
According to recent financial data for Revelation Biosciences Inc. ( REVB), the Return on Equity (ROE) stands at -340.81%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -95.82%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Revelation Biosciences Inc’s Return on Invested Capital (ROIC) is -304.37%, showcasing its effectiveness in deploying capital for earnings.
Revelation Biosciences Inc (REVB) Efficiency & Liquidity Metrics
Based on Revelation Biosciences Inc’s (REVB) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Revelation Biosciences Inc (REVB) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Revelation Biosciences Inc. (REVB) effectively leverages its workforce, generating an average of -$1293333.33 per employee. The company’s liquidity position is robust, with a Current Ratio of 3.42% and a Quick Ratio of 3.42%, indicating strong ability to cover short-term liabilities.
REVB Stock EPS
With the latest financial reports released by the company, Revelation Biosciences Inc posted -40.32/share EPS, while the average EPS was predicted by analysts to be reported at -136.32/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 96. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for REVB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Revelation Biosciences Inc go to 72.82%.
Revelation Biosciences Inc [REVB] Institutonal Ownership Details
There are presently around $1.67%, or 1.68%% of REVB stock, in the hands of institutional investors.
